The Hidden Costs of Financial Conflicts of Interest in Medicine
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
A series of three articles by Lisa Rosenbaum [1,2,3] in the New England Journal of Medicine called for a reexamination of the views and regulations of financial conflicts of interest in medicine. Her conclusions appeared to be clear: ‘The bad behavior of the few has facilitated impugning of the many' [[3], p. 2067]. The effects of this behavior were amplified by journalists who fed a vicious cycle in which each story generates more distrust in the public. Dr. Rosenbaum suggested that current restrictive rules may ‘undermine potentially productive research collaborations, dissemination of expertise, and public trust' [[3], p. 2068]. She acknowledged that studies by pharmaceutical companies are more likely to have outcomes favorable to the sponsor [4] and that physicians who attend events funded by pharmaceutical companies tend to prescribe the featured drugs [5]. However, she claimed that these interactions might actually be beneficial to the patient and that much of the harm was ‘invented'. Dr. Rosenbaum's views were in sharp contrast with the history of the journal where they were published. The New England Journal of Medicine pioneered the need of disclosure of financial conflicts of interests [6] and the importance of having authors of editorials and review articles free from commercial ties [7], yet time seems to be ripe for getting rid of these worries and to return to business as usual. A recent viewpoint published in the JAMA [8] moves toward this direction. Also, these authors complain of the policies on conflicts of interest that were developed in reaction to a limited number of investigators but, once introduced, applied to all. They suggested substituting the pejorative term of ‘conflict of interest' with ‘confluence of interest'. A name change can be important. When withdrawal reactions started being described following the discontinuation of second-generation antidepressant drugs (selective serotonin reuptake inhibitors, SSRI) they were promptly labeled as ‘discontinuation syndromes' [9]. The name successfully conferred a harmless nature, which was in sharp contrast with the withdrawal reactions that occurred with other drugs like benzodiazepines [10]. SSRI thus replaced benzodiazepines in the treatment of anxiety disorders, even though discontinuation syndromes of SSRI are actually withdrawal reactions [10], and the clinical evidence was pointing to just the opposite (benzodiazepines are more effective, with fewer side effects) [11]. The shift from benzodiazepines to SSRI has probably been the most successful achievement of pharmaceutical propaganda in psychiatry, with full endorsement of guidelines and professional societies [12]. Will the term ‘confluence of interest' achieve the same success?Let us examine the development of the problem, its implications and what can be done about it.The term ‘conflict of interest' is widely used but may entail different meanings. Margolis [13] distinguishes between conflicting interests and conflicts of interest. The former occur in any situation where competing considerations are presumed to be legitimate. Conflicts of interest, on the other hand, are characterized by individuals occupying dual roles which should not be performed simultaneously. Which roles? For instance, being a researcher and holding a financial interest in an area related to the research in which one is involved. Because of the potential for abuse, performing both roles at the same time is considered to be inappropriate. Conflicts of interest may be financial (such as being paid by a private firm or deriving a financial benefit from owning a relevant patent) or nonfinancial (such as allegiance to a school of thought or political commitment). In the nineties, an impressive body of facts pointed to the dangers of conflicts of interest in medicine [14]. However, as with many cultural and scientific phenomena, these dangers tended to be overlooked, if not deliberately denied. The medical community was substantially unprepared to deal with the problem. Not surprisingly, appropriate regulations occurred in a comprehensive form only at the end of the subsequent decade [15], as an attempt to restore credibility after an endless series of scandals and not as a spontaneous development of professional societies for preventing biased research and corporate indoctrination.At the beginning, the issue was whether specific episodes that emerged were the unavoidable drawbacks of a scientific system that functioned in a substantially independent way or whether they were simply the tip of the iceberg. Books such as Jerome P. Kassirer's On the Take [16] and John Abramson's Overdosed America [17] illustrated how corporate interest manipulated science, misled doctors and threatened the health of the community, and how medical journals and medical societies had a role in this. These and many other subsequent publications, such as Whitaker and Cosgrove's Psychiatry under the Influence [18], documented a syste
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“the phenomenon of tolerance may contribute to poorer outcomes in people with depression exposed to long-term antidepressant treatment, although as noted earlier, there are many confounds of this association [95, 96].”
From The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications (2019) · cites this paper as [95]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., Goldman, J., Kassirer, J. P., Kimball, H., Naughton, J., et al. (2006) · JAMA · doi:10.1001/jama.295.4.429 · Cited by 695
Problems in the “Evidence” of “Evidence-Based Medicine”
Feinstein, A. R., & Horwitz, R. I. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00244-1 · Cited by 653
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
Choudhry, N. K. (2002) · JAMA · doi:10.1001/jama.287.5.612 · Cited by 646
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Self-citationThe Effects of Pharmaceutical Firm Enticements on Physician Prescribing Patterns
Orlowski, J. P., & Wateska, L. (1992) · Chest · doi:10.1378/chest.102.1.270 · Cited by 384
Current Concepts of Positive Mental Health
(1959) · Journal of the American Medical Association · doi:10.1001/jama.1959.03000290120032 · Cited by 335
Rothman, D. J., McDonald, W. J., Berkowitz, C. D., Chimonas, S. C., DeAngelis, C. D., Hale, R. W., Nissen, S. E., Osborn, J. E., Scully, J. H., Thomson, G. E., et al. (2009) · JAMA · doi:10.1001/jama.2009.407 · Cited by 303
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Dealing with Conflicts of Interest
Relman, A. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131209 · Cited by 249
Research works printed but not linked: 3
- Margolis J: Conflict of interest and conflicting interests; in Beauchamp TL, Bowie NE (eds): Ethical Theory and Business. Englewood Cliffs, Practice-Hall, 1979, pp 361-372. Fava Psychother Psychosom 2016;85:65-70 DOI: 10.1159/000442694 70 · doi:10.1159/00044269470
- 10.1007/978-1-137-51602-2 · doi:10.1007/978-1-137-51602-2
- Lee FLF, Chan JM: Professionalism, political orientation, and perceived self-censorship. Is- sue Stud 2008; 44: 205-238.
Cited by
Psychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Benzodiazepines as a monotherapy in depressive disorders: a systematic review
Benasi, G., Guidi, J., Offidani, E., Balon, R., Rickels, K., & Fava, G. A. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486696 · Cited by 79
Fornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
Discontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience
Fava, G. A., & Belaise, C. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000492693 · Cited by 77
Self-citationEvidence-based medicine was bound to fail: a report to Alvan Feinstein
Fava, G. A. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.01.012 · Cited by 79
Self-citation
Metadata
- Authors
- Fava, G. A.
- Affiliations
- University at Buffalo, State University of New York (US)
- Corresponding author
- Fava, Giovanni A.
- ORCID
- Fava, Giovanni A.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 2
- Pages
- 65-70
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2257986165
- Cited by
- 25
- References
- 41
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 1 · 2018: 4 · 2017: 9 · 2016: 2
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
- Social Sciences › Education › Academic integrity and plagiarism
- Keywords
- financial conflicts of interest, conflict of interest disclosure, pharmaceutical industry influence, pharmaceutical marketing, selective serotonin reuptake inhibitors, benzodiazepines, withdrawal reactions, public trust in medicine, editorial independence, New England Journal of Medicine, Journal of the American Medical Association, prescribing patterns
- MeSH terms
- Censorship, Research, Congresses as Topic, Interprofessional Relations, Periodicals as Topic, Conflict of Interest, Evidence-Based Medicine, Disclosure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Hidden Costs of Financial Conflicts of Interest in Medicine. https://app.cochat.ai/papers/10.1159/000442694
- The paper
- Fava, G. A. (2016). The Hidden Costs of Financial Conflicts of Interest in Medicine. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000442694
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.